Use of fixed-dose combinations for cardiovascular indications from 2018 to 2023: a nationwide population-based study.

MLA

Götzinger, Felix, et al. “Use of Fixed-Dose Combinations for Cardiovascular Indications from 2018 to 2023: A Nationwide Population-Based Study.” Journal of Hypertension, vol. 42, no. 10, Oct. 2024, pp. 1720–27. EBSCOhost, https://doi.org/10.1097/HJH.0000000000003789.

APA

Götzinger, F., Kieble, M., Espinosa Daudí, A., Kunz, M., Lauder, L., Böhm, M., Laufs, U., Mahfoud, F., & Schulz, M. (2024). Use of fixed-dose combinations for cardiovascular indications from 2018 to 2023: a nationwide population-based study. Journal of Hypertension, 42(10), 1720–1727. https://doi.org/10.1097/HJH.0000000000003789

Chicago

Götzinger, Felix, Marita Kieble, Andrea Espinosa Daudí, Michael Kunz, Lucas Lauder, Michael Böhm, Ulrich Laufs, Felix Mahfoud, and Martin Schulz. 2024. “Use of Fixed-Dose Combinations for Cardiovascular Indications from 2018 to 2023: A Nationwide Population-Based Study.” Journal of Hypertension 42 (10): 1720–27. doi:10.1097/HJH.0000000000003789.